H. 12 de Octubre

Madrid 28041

1 studies enrolling now · 2 studies all time

What they study most

Endometrial Cancer, Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation

Studies at this site

• Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation — Recruiting now
• Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling